Genotype-phenotype Correlation Study of Presymptomatic and Symptomatic DFNA9 Patients
Evaluation of Hearing and Vestibular Function in Presymptomatic and Symptomatic DFNA9 Patients Carrying the Pro51Ser (P51S) Mutation in the COCH Gene.
Jessa Hospital
70 participants
Jun 1, 2018
OBSERVATIONAL
Conditions
Summary
DFNA9 (Deafness Autosomal Dominant 9) is an autosomal dominant hereditary hearing loss which is associated with vestibular deterioration. The most recent genotype-phenotype correlation studies have been conducted more than 15 years ago. Meanwhile, emerging and valuable vestibular tests have been added to the vestibular test battery. These tests were not available at the time of the correlation studies. The aim of this study is to carry out a prospective cross-sectional study on symptomatic and presymptomatic affected carriers of the Pro51Ser (P51S) Coagulation Factor C Homology (COCH) mutation in order to correlate vestibular data using the complete vestibular test battery with the known data on hearing and vestibular function in relation to age.
Eligibility
Inclusion Criteria2
- subject must be 18 year of older
- subject is a family member of the family pedigree's proband(s) carrying a P51S COCH mutation
Exclusion Criteria8
- subject is younger than 18 years
- subject is not a family member of the pedigree's proband(s) carrying a P51S
- subject cannot undergo investigations (medical and/or mental reasons)
- subject is not willing to be enrolled into the study
- subject suffers other concomitant middle or inner ear disease
- subject has undergone middle ear or inner ear surgery
- subject suffers other concomitant vestibular disease than DFNA9
- subject has undergone vestibular surgery or other non-invasive vestibular treatment (gentamicin intratympanal injections for example)
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03716908